共 41 条
- [31] SILEN-C3: TREATMENT FOR 12 OR 24 WEEKS WITH BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAiVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTIONHEPATOLOGY, 2011, 54 : 378A - 378ADieterich, DouglasAsselah, TarikGuyader, DominiqueBerg, ThomasCeausu, EmanoilPreotescu, LilianaSchuchmann, MarcusMauss, StefanRatziu, VladFerenci, PeterLarrey, Dominique G.Maieron, AndreasBiermer, MichaelStern, Jerry O.Scherer, JoeKubiak, ReneBoecher, Wulf O.
- [32] Eight weeks of treatment with the long acting, human GLP-1 analogue R1583 improves glycemic control and lowers body weight in subjects with type 2 diabetes mellitus (T2DM) treated with metformin: A double-blind placebo-controlled phase 2 studyDIABETES, 2008, 57 : A33 - A33Balena, RaffaellaRatner, RobertBerria, RacheleAsnaghi, VeronicaGrant, RachelaSnaith, JohnBoldrin, MarkNauck, Michael
- [33] SARILUMAB, A FULLY HUMAN MAB AGAINST IL-6R ALPHA, SUBCUTANEOUSLY-ADMINISTERED SHOWS SIGNIFICANT IMPROVEMENT IN RA PATIENTS AS EARLY AS 2 WEEKS: A TIME TO EVENT ANALYSIS FOR ACR50 AND EULAR GOOD RESPONSEANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 627 - 628Fleischmann, R.Fiore, S.Fan, C.Thompson, D.
- [34] Intake of omega-3 formulation EPA:DHA 6:1 by old rats for 2 weeks improved endothelium-dependent relaxations and normalized the expression level of ACE/AT1R/NADPH oxidase and the formation of ROS in the mesenteric arteryBIOCHEMICAL PHARMACOLOGY, 2020, 173Farooq, Muhammad A.Gaertner, SebastienAmoura, LamiaNiazi, Zahid R.Park, Sin-HeeQureshi, Abdul W.Oak, Min-HoToti, FlorenceSchini-Kerth, Valerie B.Auger, Cyril
- [35] Association of common haplotypes of the p85a subunit of phosphoinositide 3-kinase gene (PIK3R1) with glycemic response to 26 weeks of treatment with an insulin sensitizing PPAR-g/a agonist in type 2 diabetic patientsDIABETES, 2006, 55 : A258 - A258Hansen, LarsEkstrom, Claus T.Palacios, Rene TabanarayAnant, MadanWassermann, KarstenReinhardt, Rickey R.
- [36] Efficacy of 24 weeks of treatment with peginterferon alfa-2b 1.5 μg/kg/week plus ribavirin 800-1400 mg/day (p/r) in patients infected with chronic hepatitis C with genotype 1 of low viral load (IvIgI)GASTROENTEROLOGY, 2005, 128 (04) : A718 - A718Zeuzem, SEsteban-Mur, RButi-Ferrer, MFerenci, PSperl, JHorsmans, YCianciara, JIbranyi, EWeiland, OManesis, ERizzetto, MSola-Lamoglia, RNoviello, SBrass, C
- [37] Once-daily oral small molecule GLP-1R agonist PF-07081532 robustly reduces glucose and body weight within 4-6 weeks in adults with type 2 diabetes and non-diabetic adults with obesityDIABETOLOGIA, 2022, 65 (SUPPL 1) : S60 - S60Buckeridge, C.Tsamandouras, N.Carvajal-Gonzalez, S.Brown, L. S.Chidsey, K. L.Saxena, A. R.
- [38] Re:: Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer -: !Tomlins SA, !Rhodes DR, !Perrier S, !Dhanasekaran SM, !Mehra R, !Sun XW, !Varambally S, !Cao X, !Tchinda J, !Kuefer R, !Lee C, !Montie JE, !Shah RB, !Pienta KJ, !Rubin MA, !Chirmaiyan AMEUROPEAN UROLOGY, 2007, 51 (05) : 1443 - 1444Schroder, Fritz H.
- [39] Ritonavir-boosted danoprevir plus Peg-IFNα-2a/ribavirin (P/R) demonstrates up to 100% SVR24 with 12 or 24 weeks of total treatment in treatment-naive patients with HCV genotype 4 infection in the DAUPHINE studyHEPATOLOGY, 2012, 56 : 557A - 557AHezode, ChristopheShiffman, Mitchell L.Cooper, CurtisEverson, Gregory T.Marcellin, PatrickRodriguez-Torres, MaribelBourliere, MarcPol, StanislasRichardson, DeniseNavarro, Mercidita T.Voulgari, AthinaShulman, NancyYetzer, Ellen S.
- [40] Burden of IBS-Diarrhea Symptoms Tracked With Daily Journals for 12 Weeks in a Randomized, Double-Blind, Placebo-Controlled Study of Lactobacillus AcidophilusCL1285, L. Casei LBC80R and L. Rhamnosus CLR2AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S296 - S297Ship, NoamMallais, CynthiaCarriere, Serge